
John Munn Kirkwood MD
Melanoma
Distinguished Professor of Medicine, Dermatology & Translational Science; Usher Endowed Professor of Medicine, University of Pittsburgh School of Medicine; Co-Director Melanoma and Skin Cancer Program, UPMC Hillman Cancer Institute
Join to view full profile
5150 Centre Ave# CancerPittsburgh, PA 15232
Phone+1 412-692-4724
Dr. Kirkwood is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- John Kirkwood, MD, is an internationally respected medical oncologist based in Pittsburgh, PA, with a focus upon melanoma. His education includes residency in Internal Medicine at Yale and Fellowship in Medical Oncology at Harvard Dana-Farber Cancer Institute. Since 1986, he has been Director of the Melanoma and Skin Cancer Program at UPMC Hillman he is Distinguished Professor of Medicine, Dermatology, and Translational Science at UPMC Hillman Cancer Center. Dr. Kirkwood has expertise all phases of melanoma and has contributed 600 publications and been involved in >300 clinical trials. He has been inducted into the Association of American Physicians and Giants of Cancer Care, and for >20 years America's Top Doctors for Cancer and Pittsburgh Magazine Best Doctors among others.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1977 - 1979
Yale-New Haven Medical CenterResidency, Internal Medicine, 1973 - 1976
Yale School of MedicineClass of 1973
Certifications & Licensure
PA State Medical License 1986 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors for Cancer Castle Connolly, 2005-2019
- Pittsburgh Magazine Best Doctors Castle Connolly, 2005-2019
- Distinguished Service Professor of Medicine University of Pittsburgh, 2018
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsPurinergic activity of circulating extracellular vesicles associates with disease progression in melanoma.Yana G Najjar, Chang Sook Hong, Elizabeth V Menshikova, John M Kirkwood, Brenda Diergaarde
Oncoimmunology. 2026-12-31 - Nectin-4 as predictive biomarker of immune-related adverse event subtypes in adjuvant anti-programmed-death-1 treatment of melanoma.Sabrina Bruno, Andrew D Knight, Caroline J Layding, Hong Wang, Walter J Storkus
Melanoma Research. 2026-10-01 - Evidence of genetic susceptibility to immune-related dermatitis in patients with melanoma treated with immune checkpoint inhibitors.Ahmad A Tarhini, Mohammad Ali Khaksar, Zhihua Chen, Sandra J Lee, F Stephen Hodi
Melanoma Research. 2026-10-01
Journal Articles
- Prognostic Gene Expression Profiling in Cutaneous MelanomaDouglas Grossman, Sancy A Leachman, Larissa Korde, Elizabeth I Buchbinder, Emily Y Chu, Julia A Curtis, Laura K Ferris, Kenneth F Grossmann, Siwen Hu-Lieskovan, Kari L..., JAMA Dermatology
- Psychosocial Impact of Skin Biopsies in the Setting of Melanoma Screening – A Cross‐Sectional SurveyM A Weinstock, L K Ferris, N H Matthews, J M Kirkwood, F Solano, M Saul, A C Geller, The British Journal of Dermatology
Authored Content
- Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
Press Mentions
Immunotherapy After Surgery Shows Promise in Treating Rare, Aggressive Skin CancerOctober 20th, 2025
Dysfunctional B Cells: New Cancer Immunotherapy TargetFebruary 20th, 2025
Scientists Identify a New Cancer Immunotherapy Target: Dysfunctional B CellsFebruary 19th, 2025
Grant Support
- NCI NCTN-Network Lead Academic Participating Site at UPMC Hillman Cancer CenterUNIVERSITY OF PITTSBURGH AT PITTSBURGH2019–2032
- Melanoma and Skin Cancer Program SPOREUNIVERSITY OF PITTSBURGH AT PITTSBURGH2021–2026
- Spore In Skin CancerNational Cancer Institute2008–2011
- Immunologic &Genetic Determinants Of Outcome &Response To Ifn-A2b TherapyNational Cancer Institute2008–2011
- Career Development ProgramNational Cancer Institute2008–2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: